C. Norman Coleman, M.D., holds an undergraduate degree in mathematics from the University of Vermont and received his medical training at Yale University School of Medicine. Dr. Coleman completed his internship and residency in internal medicine at the University of California, San Francisco, and a fellowship in medical oncology at NCI.
More…Killing cancer cells while minimizing damage to healthy cells is the goal of radiation therapy. About half of all patients with cancer undergo radiation therapy, the majority of these with curative intent. Finding new ways of using radiation therapy more effectively and with fewer side effects is paramount for maintaining patients’ quality of life. This entails innovative uses of technology and biology and integration in multimodality cancer care and research.
As part of an ongoing effort to stimulate research in radiotherapy and radiation biology, the Radiation Research Program (RRP) supports clinical, translational, and basic research at the Division of Cancer Treatment and Diagnosis (DCTD) by:
RRP also coordinates its activities with other radiation research programs at NCI, the National Institutes of Health (NIH), other federal agencies, and national and international research organizations. Additionally, RRP serves as a focal point for extramural investigators concerned with clinically related radiation oncology and biology research.
RRP supports research involving a variety of radiation therapeutic modalities:
The RRP encompasses three branches: